Association study of two cannabinoid receptor genes, CNR1 and CNR2, with methamphetamine dependence

Current Neuropharmacology

Volumn 9, Issue 1, 2011, Pages 183-189

  Okahisa, Y ^a   Kodama, M ^a   Takaki, M ^a   Inada, T ^b,c   Uchimura, N ^b,d   Yamada, M ^b,e   Iwata, N ^b,f   Iyo, M ^b,g   Sora, I ^b,h   Ozaki, N ^b,i   Ujike, H ^a,b  

^a OKAYAMA UNIVERSITY   (Japan)

^b JGIDA ^*  (Japan)

^c SEIWA HOSPITAL   (Japan)

^d Kurume University Graduate School of Medicine Kurume University Graduate School of Medicine Graduate School Biostatistics   (Japan)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^f FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cannabinoid receptor 1; Cannabinoid receptor 2; Case control association; Methamphetamine; Substance abuse

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; METHAMPHETAMINE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; DRUG USE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PSYCHOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79953055796     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015911795017191     Document Type: Article

References (41)

1. van der Stelt, M.; Di Marzo, V. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur. J. Pharmacol., 2003, 480, 133-150.
2. Matsuda, L.A.; Lolait, S.J.; Brownstein, M.J.; Young, A.C.; Bonner, T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 1990, 346, 561-564.
3. Herkenham, M.; Lynn, A.B.; Johnson, M.R.; Melvin, L.S.; de Costa, B.R.; Rice, K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci., 1991, 11, 563-583.
4. Herkenham, M.; Lynn, A.B.; Little, M.D.; Johnson, M.R.; Melvin, L.S.; de Costa, B.R.; Rice, K.C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. USA, 1990, 87, 1932-1936.
5. Matsuda, L.A.; Bonner, T.I.; Lolait, S.J. Localization of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol., 1993, 327, 535-550.
6. Tsou, K.; Brown, S.; Sanudo-Pena, M.C.; Mackie, K.; Walker, J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience, 1998, 83, 393-411.
7. De Vries, T.J.; Schoffelmeer, A.N. Cannabinoid CB1 receptors control conditioned drug seeking. Trends Pharmacol. Sci., 2005, 26, 420-426.
8. Forget, B.; Hamon, M.; Thiebot, M.H. Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats. Psychopharmacology (Berl), 2005, 181, 722-734.
9. Colombo, G.; Serra, S.; Vacca, G.; Carai, M.A.; Gessa, G.L. Endocannabinoid system and alcohol addiction: pharmacological studies. Pharmacol. Biochem. Behav., 2005, 81, 369-380.
10. Racz, I.; Bilkei-Gorzo, A.; Toth, Z.E.; Michel, K.; Palkovits, M.; Zimmer, A. A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking. J. Neurosci., 2003, 23, 2453-2458.
11. Maldonado, R.; Valverde, O.; Berrendero, F. Involvement of the endocannabinoid system in drug addiction. Trends Neurosci., 2006, 29, 225-232.
12. Yamamoto, T.; Takada, K. Role of cannabinoid receptor in the brain as it relates to drug reward. Jpn. J. Pharmacol., 2000, 84, 229-236.
13. Agrawal, A.; Wetherill, L.; Dick, D.M.; Xuei, X.; Hinrichs, A.; Hesselbrock, V.; Kramer, J.; Nurnberger, J.I., Jr.; Schuckit, M.; Bierut, L.J.; Edenberg, H.J.; Foroud, T. Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. Am. J. Med. Genet. B Neuropsychiatr. Genet., 2008, 150, 736-40.
14. Chen, X.; Williamson, V.S.; An, S.S.; Hettema, J.M.; Aggen, S.H.; Neale, M.C.; Kendler, K.S. Cannabinoid receptor 1 gene association with nicotine dependence. Arch. Gen. Psychiatry, 2008, 65, 816-824.
15. Comings, D.E.; Muhleman, D.; Gade, R.; Johnson, P.; Verde, R.; Saucier, G.; MacMurray, J. Cannabinoid receptor gene (CNR1): association with i.v. drug use. Mol. Psychiatry, 1997, 2, 161-168.
16. Herman, A.I.; Kranzler, H.R.; Cubells, J.F.; Gelernter, J.; Covault, J. Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence. Am. J. Med. Genet. B Neuropsychiatr. Genet., 2006, 141, 499-503.
17. Hopfer, C.J.; Young, S.E.; Purcell, S.; Crowley, T.J.; Stallings, M.C.; Corley, R.P.; Rhee, S.H.; Smolen, A.; Krauter, K.; Hewitt, J.K.; Ehringer, M.A. Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. Am. J. Med. Genet. B Neuropsychiatr. Genet., 2006, 141, 895-901.
18. Schmidt, L.G.; Samochowiec, J.; Finckh, U.; Fiszer-Piosik, E.; Horodnicki, J.; Wendel, B.; Rommelspacher, H.; Hoehe, M.R. Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend., 2002, 65, 221-224.
19. Zuo, L.; Kranzler, H.R.; Luo, X.; Covault, J.; Gelernter, J. CNR1 variation modulates risk for drug and alcohol dependence. Biol. Psychiatry, 2007, 62, 616-626.
20. Ballon, N.; Leroy, S.; Roy, C.; Bourdel, M.C.; Charles-Nicolas, A.; Krebs, M.O.; Poirier, M.F. (AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population. Pharmacogenomics J., 2006, 6, 126-130.
21. Covault, J.; Gelernter, J.; Kranzler, H. Association study of cannabinoid receptor gene (CNR1) alleles and drug dependence. Mol. Psychiatry, 2001, 6, 501-502.
22. Li, T.; Liu, X.; Zhu, Z.H.; Zhao, J.; Hu, X.; Ball, D.M.; Sham, P.C.; Collier, D.A. No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population. Mol. Psychiatry, 2000, 5, 128-130.
23. Ponce, G.; Hoenicka, J.; Rubio, G.; Ampuero, I.; Jimenez-Arriero, M.A.; Rodriguez-Jimenez, R.; Palomo, T.; Ramos, J.A. Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients. Mol. Psychiatry, 2003, 8, 466-467.
24. Zhang, P.W.; Ishiguro, H.; Ohtsuki, T.; Hess, J.; Carillo, F.; Walther, D.; Onaivi, E.S.; Arinami, T.; Uhl, G.R. Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol. Psychiatry, 2004, 9, 916-931.
25. Berdyshev, E.V. Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids, 2000, 108, 169-190.
26. Munro, S.; Thomas, K.L.; Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature, 1993, 365, 61-65.
27. Sugiura, T.; Waku, K. 2-Arachidonoylglycerol and the cannabinoid receptors. Chem. Phys. Lipids, 2002, 108, 89-106.
28. Onaivi, E.S.; Carpio, O.; Ishiguro, H.; Schanz, N.; Uhl, G.R.; Benno, R. Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption. Ann. N. Y. Acad. Sci., 2008, 1139, 426-433.
29. Onaivi, E.S.; Ishiguro, H.; Gong, J.P.; Patel, S.; Meozzi, P.A.; Myers, L.; Perchuk, A.; Mora, Z.; Tagliaferro, P.A.; Gardner, E.; Brusco, A.; Akinshola, B.E.; Hope, B.; Lujilde, J.; Inada, T.; Iwasaki, S.; Macharia, D.; Teasenfitz, L.; Arinami, T.; Uhl, G.R. Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects. PLoS ONE, 2008, 3, e1640.
30. Onaivi, E.S.; Ishiguro, H.; Gong, J.P.; Patel, S.; Perchuk, A.; Meozzi, P.A.; Myers, L.; Mora, Z.; Tagliaferro, P.; Gardner, E.; Brusco, A.; Akinshola, B.E.; Liu, Q.R.; Hope, B.; Iwasaki, S.; Arinami, T.; Teasenfitz, L.; Uhl, G.R. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann. N. Y. Acad. Sci., 2006, 1074, 514-536.
31. Van Sickle, M.D.; Duncan, M.; Kingsley, P.J.; Mouihate, A.; Urbani, P.; Mackie, K.; Stella, N.; Makriyannis, A.; Piomelli, D.; Davison, J.S.; Marnett, L.J.; Di Marzo, V.; Pittman, Q.J.; Patel, K.D.; Sharkey, K.A. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science, 2005, 310, 329-332.
32. Sipe, J.C.; Arbour, N.; Gerber, A.; Beutler, E. Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders. J. Leukoc. Biol., 2005, 78, 231-238.
33. Karsak, M.; Cohen-Solal, M.; Freudenberg, J.; Ostertag, A.; Morieux, C.; Kornak, U.; Essig, J.; Erxlebe, E.; Bab, I.; Kubisch, C.; de Vernejoul, M.C.; Zimmer, A. Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum. Mol. Genet., 2005, 14, 3389-3396.
34. Ishiguro, H.; Iwasaki, S.; Teasenfitz, L.; Higuchi, S.; Horiuchi, Y.; Saito, T.; Arinami, T.; Onaivi, E.S. Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans. Pharmacogenomics J., 2007, 7, 380-385.
35. Onaivi, E.S.; Ishiguro, H.; Gong, J.P.; Patel, S.; Meozzi, P.A.; Myers, L.; Perchuk, A.; Mora, Z.; Tagliaferro, P.A.; Gardner, E.; Brusco, A.; Akinshola, B.E.; Liu, Q.R.; Chirwa, S.S.; Hope, B.; Lujilde, J.; Inada, T.; Iwasaki, S.; Macharia, D.; Teasenfitz, L.; Arinami, T.; Uhl, G.R. Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression. Ann. N. Y. Acad. Sci., 2008, 1139, 434-449.
36. Ujike, H.; Sato, M. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann. N. Y. Acad. Sci., 2004, 1025, 279-287.
37. Hartman, C.A.; Hopfer, C.J.; Haberstick, B.; Rhee, S.H.; Crowley, T.J.; Corley, R.P.; Hewitt, J.K.; Ehringer, M.A. The association between cannabinoid receptor 1 gene (CNR1) and cannabis dependence symptoms in adolescents and young adults. Drug Alcohol Depend., 2009, 104, 11-16.
38. Hoenicka, J.; Ponce, G.; Jimenez-Arriero, M.A.; Ampuero, I.; Rodriguez-Jimenez, R.; Rubio, G.; Aragues, M.; Ramos, J.A.; Palomo, T. Association in alcoholic patients between psychopathic traits and the additive effect of allelic forms of the CNR1 and FAAH endocannabinoid genes, and the 3' region of the DRD2 gene. Neurotox. Res., 2007, 11, 51-60.
39. Preuss, U.W.; Koller, G.; Zill, P.; Bondy, B.; Soyka, M. Alcoholism-related phenotypes and genetic variants of the CB1 receptor. Eur. Arch. Psychiatry Clin. Neurosci., 2003, 253, 275-280.
40. Zuo, L.; Kranzler, H.R.; Luo, X.; Yang, B.Z.; Weiss, R.; Brady, K.; Poling, J.; Farrer, L.; Gelernter, J. Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample. Neuropsychopharmacology, 2009, 34, 1504-1513.
41. De Marchi, N.; De Petrocellis, L.; Orlando, P.; Daniele, F.; Fezza, F.; Di Marzo, V. Endocannabinoid signalling in the blood of patients with schizophrenia. Lipids Health Dis., 2003, 2, 5.